Telehealth intervention combining exercise and stimulation for people with tetraplegia
Official title: Transspinal Stimulation With and Without Blood Flow Restricted Exercise Via Telehealth in Persons With Tetraplegia
Run by Virginia Commonwealth University · NCT05423600 · Data updated 2026-11-12
This study is testing whether a new home-based program that combines special exercises and nerve stimulation can help people with tetraplegia improve their movement and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 44 (estimated) |
| Sponsor | Virginia Commonwealth University Academic / other |
| Locations | 3 sites (Richmond, Virginia and 2 other locations) |
| Status | Recruiting |
| Started | June 15, 2022 |
| Main results expected | November 2026 |
| Study ends | November 2026 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT05423600 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with chronic, incomplete tetraplegia who are at least one year post spinal cord injury and have a neurologic level of C8 or above.
✕Probably not a fit
Patients with complete spinal cord injuries or those who do not have the necessary technology for telehealth participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a home-based intervention that combines Blood Flow Restricted Exercise (BES) and Transspinal Stimulation (TS) in improving motor and functional abilities in individuals with chronic, incomplete tetraplegia. Participants will engage in a 30-week program that includes telehealth support, education, and practice sessions. The study aims to determine if this combined approach yields better outcomes than BES with sham TS. The intervention is designed to enhance upper extremity function and overall quality of life for those affected by cervical spinal cord injuries.
Why it matters
Potential benefit: If successful, this intervention could significantly improve motor function and quality of life for patients with tetraplegia.
How similar studies have gone: Other studies have shown promise with similar telehealth and stimulation approaches, but this specific combination is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. A written clearance from the study medical doctor to ensure that the participant is safely able to engage in the study. 2. Participants must have a companion that will be able to help him/her throughout the study. 3. Greater than 1-year post SCI, neurologic level of C8 or above. 4. American Spinal Injury Association Impairment Scale (AIS) scores of B, C, or D indicating presence of an incomplete SCI. 5. Visible muscle contraction response to NMES wrist extensors, bilaterally. 6. Agreement to use telehealth services for delivery of research exercise training by study staff. Possesses appropriate technology to engage in telehealth including a personal web camera, computer, microphone, speakers, and high-speed broadband internet connection, valid email address (needed to obtain VA issued video conferencing software), and telephone number used to obtain login credentials for the In-Home Video Software - Cisco Jabber Video for Telepresence Software. 7. Response of muscle contraction of wrist extensors bilaterally to neuromuscular electrical stimulation. Exclusion Criteria: 1. Unhealed fracture in upper or lower extremities. 2. Severe scoliosis, severe upper extremity contractures, or other musculoskeletal issues that would impede participation in a BES + TS intervention or valid evaluation of outcome measures. 3. High resting blood pressure greater than 140/80 mmHg. 4. Taking anti-coagulants or anti-platelet agents, including aspirin if unable to be off this medication for medical reasons. 5. Pregnancy (female participants). A home pregnancy test will be conducted to role out any pregnancy before the study at the McGuire VAMC. The test will be repeated every month during the course of the study. 6. Implanted pacemakers and/or implanted defibrillator devices. 7. Other exclusion criteria may include the presence of implanted electrical device, cancer, thrombosis, pacemaker, defibrillator, or seizures. Patients who are currently on or receive anti-platelet or anticoagulant medications will be excluded from the trial. 8. Any condition that, in the judgment of the principal investigator or medical provider, precludes safe participation in the study. 9. Other exclusion criteria at the discretion of the medical team may include: 1. Uncontrolled autonomic dysreflexia (AD), refers to episodes of AD that do not respond to medications to ensure stable blood pressure in persons with SCI 2. Concurrent severe neurological injuries other than SCI: MS, CP, severe TBI, and stroke. 3. Unresolved deep vein thrombosis. 4. Psychiatric or cognitive impairments that preclude adherence to the intervention. 5. Known cardiac pathology that precludes safe participation. 6. Metabolic conditions such as cardiovascular disease, uncontrolled type II diabetes mellitus, uncontrolled hypertension, and those on insulin. 7. Presence of pressure sores stage three or greater. 8. Presence of a symptomatic urinary tract infection. 9. Severe spasticity as assessed by the Modified Ashworth Scale. 10. Changing neurologic status due to conditions such as progressive posttraumatic syringomyelia.
Where it's running
-
Sheltering Arms Physical Rehabilitation Centers
Richmond, Virginia, United States Recruiting -
Richmond VA Medical Center
Richmond, Virginia, United States Recruiting -
Virginia Commonwealth University
Richmond, Virginia, United States Recruiting
Study contacts
- Principal investigator: Ashraf Gorgey, MPT, PhD, FACSM, FACRM — Virginia Commonwealth University
- Study coordinator: Ashraf Gorgey, MPT, PhD, FACSM, FACRM
- Email: Ashraf.Gorgey@va.gov
- Phone: 804-675-5000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
Robotic upper-limb rehab vs standard therapy for adults with tetraplegia
This study tests whether a robotic arm rehabilitation device (PABLO®) plus standard therapy helps people with tetraplegia recover more upper-limb strength than standard rehab alone.
-
Wireless implant for brain-computer interface in people with tetraplegia from spinal cord injury
This trial tests a wireless brain-computer interface implanted in adults with tetraplegia to see if it is safe and if it can help restore some function.
-
Implanted brain interface to let people with severe paralysis control assistive devices
It will try an implanted brain interface that records and stimulates brain signals so adults with severe paralysis can control assistive devices and receive sensory feedback.
-
Connexus® Brain-Computer Interface to restore communication and device control
This study will try the Connexus brain-computer interface to help people with severe loss of voluntary movement (for example from ALS, cervical spinal cord injury, or stroke) communicate and control computers.
-
Robotic implantation of a precise brain‑computer interface to restore communication
This project tests whether a robotically implanted Neuralink N1 brain implant can help adults with severe, irreversible speech loss from ALS, spinal cord injury, or stroke communicate again.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.